A newly near-β titanium alloy Ti-7Mo-3Cr-3Nb-3Al (Ti-7333) was subjected to β phase solution treatment and ageing in the present work. The characteristics of α phase transformation in ageing treatment were studied. Results show that isothermal aging at a low temperature (350) will result in lots of ω particles with small size homogeneously distributing in the parent phase. These ω particles can act as nucleation sites for α phase and lead to the uniform precipitation of fine α phase within the β grain after further ageing treatment. However, when ageing at a higher temperature, the α phase tends to precipitate direct from the β matrix and the morphology of α phase is determined by the temperature and period of ageing treatment. After aging at 550 for 5min, acicular α phase precipitates in the β grains as well as along β grain boundaries and the size and quantity of α phase increase with the holding time. Note that Ti-7333 alloy has a quick ageing response. When aging at 700 for 1h, coarser α laths precipitate both on the grain boundary and within the grain. Increase the ageing temperature to 800, α phase precipitates within the β grain as short rod-like morphology. It is suggested that the driving force for α phase nucleation and the amount of defects in the intragranular decrease with the increasing of temperature, leading to the grain boundaries become the prior nucleation sites. Substantial α phase precipitate-free regions adjacent to β grain boundaries remained after ageing at 700 for 1h due to the rejection of β-stabilizer from coarse α lath on β grain boundaries. Aging at 800 for 1h resulted in pronounced continuous α-films along β grain boundaries.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.